CHPA meeting request
This article was originally published in The Rose Sheet
Executive Summary
Consumer Healthcare Products Association says meeting with FDA is planned in June to discuss the results of a pilot study on 20% benzocaine-containing oral care products. Trade group requested a meeting with the agency in a March 25 letter. Study was conducted after CHPA received a feedback letter from FDA in October 2002, responding to the association's proposed research program on benzocaine for temporary pain relief from toothache. Results address several key questions outlined by FDA, CHPA says, including "assessment of the subject's comprehension of the label directions for dosing, methodology to assess efficacy and the duration of treatment effect." CHPA also plans to discuss proposed protocol to evaluate 10% and 20% benzocaine and proposed OTC label...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.